Poseida Therapeutics PSTX 深 沪
等待开盘 04-02 09:30:00 美东时间
9.50
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 9.50
- 总市值 9.26亿
- 52周最高 9.67
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 1.87
- 委 比 0.00%
- 总股本 9746.67万
- 历史最高 17.62
- 量 比 0
- 振 幅 0.00%
- 历史最低 1.54
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多MBX Biosciences Appoints Karen Basbaum as Chief Business Officer
MBX Biosciences appoints Karen Basbaum as Chief Business Officer. With over 20 years of experience in biopharmaceutical corporate strategy and transactions, including leading deals worth billions, Basbaum will drive strategic partnerships and growth for the company's innovative peptide therapies targeting endocrine and metabolic disorders.
03-10 12:00
Poseida Therapeutics Undergoes Merger and Delisting Changes
Poseida Therapeutics ( ($PSTX) ) has provided an update. Poseida Therapeutics h...
2025-01-08 22:18
罗氏计划完成对美国生物制药公司Poseida的收购
格隆汇1月8日｜罗氏周三表示，计划完成对美国生物制药公司Poseida Therapeutics的收购，交易对价约15亿美元。此次收购于去年11月宣布，是罗氏为...
2025-01-08 15:58
罗氏(RHHBY.US)将完成15亿美元收购美国生物制药公司Poseida(PSTX.US)
罗氏周三表示，计划完成对美国生物制药公司Poseida Therapeutics的收购。
2025-01-08 15:52
Roche to close $1.5B acquisition of Poseida Therapeutics
Roche (OTCQX:RHHBY) (OTCQX:RHHBF) will finalize the acquisition of Poseida Therapeutics (NASDAQ:PSTX), a biopharmaceutical company specializing in complex immune cell therapies to treat several types ...
2025-01-08 15:43
UPDATE 1-Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida
Adds details, background, comment ZURICH, Jan 8 (Reuters) - Roche ROG.S on Wednesday said it planned to complete its purchase of U.S. biopharmaceutical company Poseida Therapeutics PSTX.O, a specialis...
2025-01-08 14:54
BRIEF-Roche Purchases Shares Of Poseida Therapeutics, Inc. In Tender Offer
Jan 8 (Reuters) - ROCHE HOLDING AG ROG.S: ROCHE PURCHASES SHARES IN TENDER OFFER FOR POSEIDA THERAPEUTICS, INC. ACCEPTS PAYMENT FOR POSEIDA SHARES AT $9.00 PER SHARE PLUS CVR TENDER OFFER EXPIRED ON 7...
2025-01-08 14:17
Momentum reigned 2024: Buy-rated U.S. stocks with the highest RSI
Momentum was the best trading factor group in 2024, up 19%, according to BofA Securities. Below are buy-rated U.S. stocks by SA Quant Metrics (with Quant ratings of at least 4.5) and the highest relat...
2025-01-04 02:28
Top-rated smaller defensive stocks after Societe Generale permabear takes contrarian view
Wall Street has had a banner 2024, with the benchmark S&P 500 (SP500) up more than 25% YTD. Most analysts expect the inexorable bull run to continue in 2025, but Societe Generale's famously bearish Al...
2024-12-28 22:00
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PSTX, CCRN, PLL on Behalf of Shareholders
NEW YORK, Dec. 9, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or ...
2024-12-10 04:21
